Contact this trialFirst, we need to learn more about you.
Muscarinic Receptor Antagonist
Darifenacin for Amyotrophic Lateral Sclerosis
Recruiting0 awardsPhase 2
Montréal, Quebec
"This trial aims to test the safety and effectiveness of a drug called Darifenacin in patients with Amyotrophic Lateral Sclerosis (ALS). ALS is a disease that causes the death of nerve cells
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.